Atlas Trials

Rituximab Maintenance Versus Observation After R2 Induction in Previously Untreated Marginal Zone Lymphoma

Clinical trial NCT07654465 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07654465
Sponsor
Sun Yat-sen University
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Marginal Zone Lymphoma(MZL)
Start date
2026-07-01
Primary completion
2030-07-01
Enrollment
144

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.